The aim is to correct the previous findings regarding the silencing of MALAT1 in ESCC cells using microRNA.
Correction of a published study's findings in Nanoscale.
Focus on the role of ligand-functionalized hydroxyl-rich nanovectors.
Examination of the effects across different ESCC cell lines.
The correction clarifies the methodology regarding MALAT1 silencing.
Emphasis on the significant role of microRNA in oncogenic processes in ESCC.
Potential implications for enhancing targeted therapies in cancer treatment.
Abstract
Correction for ‘MicroRNA-mediated silence of onco-lncRNA MALAT1 in different ESCC cells via ligand-functionalized hydroxyl-rich nanovectors’ by Rui-Quan Li et al. , Nanoscale , 2017, 9 , 2521–2530.